Insurance Corporation has expanded its benefit packages for heart disease treatments, easing patients’ financial burdens and ensuring timely access to critical medical procedures. Janette Manaois, ...

[4] According to the guidelines, when assessing the appropriate reperfusion strategy for STEMI, one must consider the time since symptom onset, the risk of STEMI, risk of fibrinolysis, and the ...

DelveInsight’s, “HDAC Inhibitor Pipeline Insight” report provides comprehensive insights about 40+ companies and 50+ pipeline ...

Doxazosin remains a commonly used antihypertensive medication, although its use has been tainted by recent findings from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack ...